MarginsXMarginsX
Home › Markets › Health Care › VCYT

Veracyte Inc. (VCYT)

VCYT trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$24.01
-1.32% on the day
Market cap
$1.9B
Small cap
Revenue · 2025
$517.1M
+16.0% on 2024
Net income · 2025
$66.4M
12.8% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1384101/000138410126000010/0001384101-26-000010-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerVCYT on Nasdaq
SectorHealth Care
IndustryMedical Specialities
CountryUnited States
IPO year2013
SEC CIK0001384101
SEC industry codeServices-Medical Laboratories
Incorporated inDE

Financials · 2025

LineValue
Revenue$517.1M
Net income$66.4M
Operating income$57.8M
Net margin12.8%
Operating margin11.2%
Revenue growth+16.0%
Cash$362.6M
Total assets$1.4B
P/E (computed)29.2×
P/S (computed)3.7×

Warning signs

Cash runway
Cash-flow positive
$199.8M cash at September 30, 2026
Share count, 1 year
+2.1%
2025-10-31 to 2026-10-30 · +10.5% over 3 years
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
-$22.2M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$199.8M cash; operating cash flow $43.5M a quarter.Report 2026-09-30
Shares outstanding80,695,480 (2026-10-30); 79,049,173 a year earlier; 73,039,671 three years earlier.Cover page 2026-10-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, San Diego, California, United StatesPCAOB Form AP 2026-03-10
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $22.2M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$151.8M$31.5M$40.3M$199.8MNo debt tags$581.8M10-Q 2026-11-05
Q2 2026
2026-06-30
$150.3M$25.5M$45.8M$299.5MNo debt tags$561.9M10-Q 2026-07-31
Q1 2026
2026-03-31
$139.1M$28.7M$35.2M$263.1MNo debt tags$541.7M10-Q 2026-05-06
Q4 2025
2025-12-31
$140.6M$41.1M$52.6M$362.6MNo debt tags$517.1M10-K 2026-02-26
Q3 2025
2025-09-30
$131.9M$19.1M$44.8M$315.6MNo debt tags$495.1M10-Q 2026-11-05
Q2 2025
2025-06-30
$130.2M-$980K$33.6M$219.5MNo debt tags$479.1M10-Q 2026-07-31
Q1 2025
2025-03-31
$114.5M$7.0M$5.4M$186.1MNo debt tags$463.4M10-Q 2026-05-06
Q4 2024
2024-12-31
$118.6M$5.1M$24.5M$239.1MNo debt tags$445.8M10-K 2026-02-26

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B72024-03-22
Latest annual report10-K2026-02-26
Latest quarterly / interim10-Q2026-11-05
Latest current report8-K2026-11-04
Latest proxyDEFA14A2026-04-22

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+0.7%
1 month-43.6%
3 months-42.9%
Year to date-42.2%
1 year-39.0%
From 52-week high-59.8%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical Specialities

TickerCompanyPriceDayMarket cap
FTREFortrea Holdings Inc.$19.79-2.03%$1.9B
PSNLPersonalis Inc.$14.80-5.79%$1.6B
TRUPTrupanion Inc.$36.16+4.87%$1.6B
ALHCAlignment Healthcare Inc.$7.47+1.49%$1.6B
LMRILumexa Imaging Holdings Inc.$14.79-0.14%$1.4B
CLOVClover Health Investments Corp.$4.95-0.20%$2.7B
CELCCelcuity Inc.$60.57-5.90%$3.0B
FRNMFreenome Inc.$10.09-3.07%$1.1B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier